Literature DB >> 4648182

Protection by Corynebacterium parvum against tumour cells injected intravenously.

L Milas, H Mujagić.   

Abstract

Entities:  

Mesh:

Year:  1972        PMID: 4648182

Source DB:  PubMed          Journal:  Rev Eur Etud Clin Biol        ISSN: 0035-3019


× No keyword cloud information.
  6 in total

1.  Intravascular coagulation resulting from intravenous injection of C. parvum in mice.

Authors:  I A Lampert; P D Jones; T E Sadler; J E Castro
Journal:  Br J Cancer       Date:  1977-07       Impact factor: 7.640

2.  Nutritional requirements of anaerobic coryneforms.

Authors:  D A Ferguson; C S Cummins
Journal:  J Bacteriol       Date:  1978-09       Impact factor: 3.490

3.  The growth and spontaneous dissemination of melanoma B16 and Lewis lung tumour in two sub-strains of C57BL/6J mice treated with Corynebacterium parvum and/or levamisole.

Authors:  B Boeryd; A Benktson
Journal:  Clin Exp Metastasis       Date:  1983 Jul-Sep       Impact factor: 5.150

4.  Effects of Corynebacterium parvum treatment and Toxoplasma gondii infection on macrophage-mediated cytostasis of tumour target cells.

Authors:  J L Krahenbuhl; L H Lambert; J S Remington
Journal:  Immunology       Date:  1976-12       Impact factor: 7.397

5.  Effect of Corynebacterium parvum on peripheral blood platelets.

Authors:  P D Jones; T E Sadler; J E Castro
Journal:  Br J Cancer       Date:  1977-12       Impact factor: 7.640

6.  The effect of gold salts on tumour immunity and its stimulation by Corynebacterium Parvum.

Authors:  W H McBride; S Tuach; B P Marmion
Journal:  Br J Cancer       Date:  1975-11       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.